Two decades across investing and operating.

Arionix TherapeuticsCurrent

Clinical-stage biotech in-licensing differentiated immunology and oncology assets. Leads asset sourcing (200+ opportunities evaluated) and financing.

Aviceda Therapeutics

Led corporate development, BD, and financing; helped complete a $207.5M Series C (first institutional round) and supported pivotal trial design.

TalentsBeyond LLC

First-in-class SaaS platform for biotech VCs and portfolios to recruit C-suite executives; shaped product, operations, and go-to-market.

Eventide Asset Management

Partner-track venture role; sourced proprietary private biotech deals through diligence, negotiation, and close.

OrbiMed

At a ~$19B AUM healthcare-dedicated investor, led or supported 15+ investments including Pandion (→ Merck), Sierra Oncology (→ GSK), Harpoon (→ Merck), Keros, Disc Medicine, Terns, Arcutis, and Galecto.

SunTrust Robinson Humphrey

Built financial models, generated investment ideas, and served as the resident biotech expert.

Scientia Advisors (Precision for Medicine)

Advised pharma, biotech, and diagnostics clients through primary and secondary research.